Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery

By R. Sinha, Gloria J. Kim, Shuming Nie, D. Shin. Molecular Cancer Therapeutics, 2006

767 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/73b0df81932989c768df9aba812526fdeec88abd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. Omid Veiseh
2. J. Gunn
3. Miqin Zhang

In Biomedical Engineering

1. Omid Veiseh
2. J. Gunn
3. V. Patel
4. James F. Rusling
5. J. Gutkind
6. Miqin Zhang
7. Ashwinkumar A. Bhirde

In Molecular Biology

1. V. Patel
2. James F. Rusling
3. J. Gutkind
4. Miqin Zhang
5. Ashwinkumar A. Bhirde
6. Richard Leapman

Citations in the corpus

• Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging (2009, background): “Because passive targeting is available for only certain in vivo applications and does not necessarily guarantee internalization of NPs by targeted cells, NPs can be additionally modified with molecular targeting ligands to employ active cell targeting [81,82].”
• Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. (2009, background): “Nevertheless, future challenges remain, including improving specificity and stability, regulating bioavailability, and developing lower toxicity carriers.(3) 5 Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of cancer in oral oncology, representing 6% of all cases and a”